Update on basic research and clinical experience with metaiodobenzylguanidine

Medical and Pediatric Oncology

Volumn 15, Issue 4, 1987, Pages 163-169

  Beierwaltes, William H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

hyperplasia; metaiodobenzylguanidine; MIBG; neuroblastoma; pheochromocytomas

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; MONOCLONAL ANTIBODY; RADIOISOTOPE;

CHILD; COMPARATIVE STUDY; COMPUTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; METHODOLOGY; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE; PHEOCHROMOCYTOMA;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; ANTIBODIES, MONOCLONAL; CALCIUM CHANNEL BLOCKERS; FOLLOW-UP STUDIES; HUMAN; HYPERPLASIA; IODINE RADIOISOTOPES; IODOBENZENES; MAGNETIC RESONANCE IMAGING; NEUROBLASTOMA; PHEOCHROMOCYTOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0023550098     PISSN: 00981532     EISSN: 1096911X     Source Type: Journal    
DOI: 10.1002/mpo.2950150405     Document Type: Article

References (31)

1. The concentration of radioactivity from labeled epinephrine and its precursors in the dog adrenal medulla
2. Concentration of dopamine analogs in the adrenal medulla
3. Adrenal imaging agents: Rationale, synthesis, formulation and metabolism
4. Labeled dopamine concentration in human adrenal medulla and in neuroblastoma
5. Labeled dopamine concentration in pheochromocytoma
6. Imaging the adrenal medulla with an I‐131‐labeled antiadrenergic agent
7. 131I]‐iodobenzylguanidine
8. Comparison of the sodium dependency of uptake of meta‐iodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells
9. Effect of uptake ‐ one inhibitor in the uptake of norepinephrine and metaiodobenzylguanidine
10. Radiolabeled meta‐iodobenzylguanidine: Pharmacology and clinical studies
11. 131l‐metaiodobenzylguanidine
12. Scintigraphic localization of pheochromocytoma
13. 131I‐metaiodobenzylguanidine for the locating of suspected pheochromocytoma. Experience in 400 cases
14. The location of middle mediastinal pheochromocytomas
15. Malignant potential of pheochromocytoma (P): Implications for follow‐up
16. Clinical applications of 1‐131‐metaiodobenzyl‐guanidine
17. Hypertension secondary to pheochromocytoma
18. Rigorous biochemical criteria for the diagnosis of pheochromocytoma
19. Pheochromocytoma: A persistently problematic and still potentially lethal disease
20. Treatment of malignant pheochromocytoma with a new radiopharmaceutical
21. Radiopharmaceutical treatment of malignant pheochromocytoma
22. 131I‐Metaiodobenzylguanidine treatment of malignant pheochromocytomas. Society of Nuclear Medicine 31st Annual Meeting. Los Angeles. June 5‐8. 1984
23. 131l metaiodobenzylguanidine (131‐I‐MIBG) scintigraphy for the location of neuroblastoma: Preliminary experience in 10 cases
24. Biologic differences between neuroblastoma stages IV‐S and IV: Measurements of serum ferritin and E‐rosette inhibition in 30 children
25. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age‐linked classification of neuroblastomas
26. I‐131‐meta‐iodobenzylguanidine (MIBG) uptake by a wide range of neuroendocrine tumors other than pheochromocytoma and neuroblastoma
27. 131I labeled P97 specific Fab fragments in human melanoma as a basis for radiotherapy
28. Discrete radioisotope sources
29. Survival time and cure in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan therapy
30. Therapeutic application of radiolabeled monoclonal antibody UJ13A in children with neuroblastoma—a phase I study
31. The James Ewing lecture: The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer